Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner

Journal of Clinical Investigation

Volumn 110, Issue 11, 2002, Pages 1717-1727

  Lodygin, Dimitri ^a   Menssen, Antje ^a   Hermeking, Heiko ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

6 ANILINO 5,8 QUINOLINEQUINONE; CYCLIC GMP; GUANYLATE CYCLASE INHIBITOR; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL AGING; CELL PROLIFERATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIPLOIDY; DNA DAMAGE; DNA MICROARRAY; DRUG EFFECT; EMBRYO; ENZYME INHIBITION; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

EID: 0036897350     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0216588     Document Type: Article

References (49)

1. Green, D.R., and Evan, G.I. 2002. A matter of life and death. Cancer Cell. 1:19-30.
2. Hayflick, L. 1965. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37:614-636.
3. Shay, J.W., and Wright, W.E. 2000. Hayflick, his limit, and cellular ageing. Nat. Rev. Mol. Cell Biol. 1:72-76.
4. Serrano, M., and Blasco, M.A. 2001. Putting the stress on senescence. Curr. Opin. Cell. Biol. 13:748-753.
5. Campisi, J. 2001. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 11:27-31.
6. Tyner, S.D., et al. 2002. p53 mutant mice that display early ageing-associated phenotypes. Nature. 415:45-53.
7. Noda, A., Ning, Y., Venable, S.F., Pereira-Smith, O.M., and Smith, J.R. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:90-98.
8. Dellambra, E., et al. 2000. Downregulation of 14-3-3sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes. J. Cell Biol. 149:1117-1130.
9. Brown, J.P., Wei, W., and Sedivy, J.M. 1997. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science. 277:831-834.
10. Ramirez, R.D., et al. 2001. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev. 15:398-403.
11. Cristofalo, V.J., Volker, C., Francis, M.K., and Tresini, M. 1998. Age-dependent modifications of gene expression in human fibroblasts. Crit. Rev. Eukaryot. Gene Expr. 8:43-80.
12. 1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8:2540-2551.
13. Chang, B.D., et al. 1999. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene. 26:4808-4818.
14. Bast, R.C., et al., editors. 2000. Cancer Medicine. 5th Edition. BC Decker Inc. Hamilton, Canada. 2546 pp.
15. Menssen, A., and Hermeking, H. 2002. Characterization of the c-MYC-regulated transcriptome using SAGE: Identification and characterization of c-MYC-target genes. Proc. Natl. Acad. Sci. USA. 99:6274-6279.
16. Pfaffl, M.W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:2003-2007.
17. Dimri, G.P., et al. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA. 92:9363-9637.
18. el-Deity WS, et al. 1993. WAF1, a potential mediator of p53 rumor suppression. Cell. 75:817-825.
19. West, M.D., Shay, J.W., Wright, W.E., and Linskens, M.H. 1996. Altered expression of plasminogen activator and plasminogen activator inhibitor during cellular senescence. Exp. Gerontology. 31:175-193.
20. Ly, D.H., Lockhart, D.J., Lerner, R.A., and Schultz, P.G. 2000. Mitotic misregulation and human aging. Science. 287:2486-2492.
21. Shelton, D.N., Chang, E., Whittier, P.S., Choi, D., and Funk, W.D. 1999. Microarray analysis of replicative senescence. Curr. Biol. 9:939-945.
22. Giuili, G., Scholl, U., Bulle, F., and Guellaen, G. 1992. Molecular cloning of the cDNAs coding for the two subunits of soluble guanylyl cyclase from human brain. FEBS Lett. 304:83-88.
23. Giuili, G., Roechel, N., Scholl, U., Mattei, M.-G., and Guellaen, G. 1993. Colocalization of the genes coding for the alpha-3 and beta-3 subunits of soluble guanylyl cyclase to human chromosome 4 at q31.3-q33. Hum. Genet. 91:257-260.
24. Hofmann, F., Ammendola, A., and Schlossmann, J. 2000. Rising behind NO: cGMP-dependent protein kinases. J. Cell Sci. 113:1671-1676.
25. Fleisch, J.H., et al. 1984. Pharmacologic analysis of two novel inhibitors of leukotriene (slow reacting substance) release. J. Pharmacol. Exp. Ther. 229:681-689.
26. Nurse, P. 2000. A long twentieth century of the cell cycle and beyond. Cell. 100:71-78.
27. Serrano, M., Lin, A.W., McCurrach, M.E., Beach, D., and Lowe, S.W. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 88:593-602.
28. 1 cyclin-dependent kinases. Cell. 75:805-816.
29. Harper, J.W., et al. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell. 6:387-400.
30. Grana, X., Garriga, J., and Mayol, X. 1998. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth. Oncogene. 17:3365-3383.
31. Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell. 81:323-830.
32. Waldman, T., Lengauer, C., Kinzler, K.W., and Vogelstein, B. 1996. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature. 381:713-716.
33. Bunz, F., et al. 1998. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science. 282:1497-1501.
34. Myohanen, S.K, Baylin, S.B., and Herman, J.G. 1998. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res. 58:591-593.
35. Hermeking, H., et al. 1994. Role of c-myc in simian virus 40 large tumor antigen-induced DNA synthesis in quiescent 3T3-L1 mouse fibroblasts. Proc. Natl. Acad. Sci. USA. 91:10412-10416.
36. DeCaprio, J.A., et al. 1998. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell. 54:275-283.
37. Horowitz, J.M., et al. 1990. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc. Natl. Acad. Sci. USA. 87:2775-2779.
38. zur Hausen, H. 2001. Oncogenic DNA viruses. Oncogene. 20:7820-7823.
39. Hollstein, M., et al. 1999. New approaches to understanding p53 gene tumor mutation spectra. Mutat. Res. 431:7-12.
40. Schmidt, M.J., Sawyer, B.D., Truex, L.L., Marshall, W.S., and Fleisch, J.H. 1985. LY83583: An agent that lowers intracellular levels of cyclic guanosine 3′,5′-monophosphate. J. Pharmacol. Exp. Ther. 232:764-769.
41. Mulsch, A., Busse, R., Liebau, S., and Forstermann, U. 1988. LY 83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase. J. Pharmacol. Exp. Ther. 247:283-288.
42. Cherry, P.D., Omar, H.A., Farrel, K.A., Stuart, J.S., and Wolin, M.S. 1990. Superoxide anion inhibits cGMP-associated bovine pulmonary arterial relaxation. Am. J. Physiology. 259:1056-1062.
43. Helt, C.E., Rancourt, R.C., Staversky, R.J., and O'Reilly, M.A. 2001. p53-dependent induction of p21(Cip1/WAF1/Sdi1) protects against oxygen-induced toxicity. Toxicol. Sci. 63:214-222.
44. Hartwell, L.H., Szankasi, P., Roberts, C.J., Murray, A.W., and Friend, S.H. 1997. Integrating genetic approaches into the discovery of anticancer drugs. Science. 278:1064-1068.
45. Batchelor, D. 2001. Hair and cancer chemotherapy: Consequences and nursing care - A literature study. Eur. J. Cancer Care. 10:147-163.
46. Patridge, A.H., Burstein, H.J., and Winer, E.P. 2001. Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer. J. Natl. Cancer Inst. Monogr. 30:135-142.
47. Felix, C.A. 1998. Secondary leukemias induced by topoisomerase-targeted drugs. Biochim. Biophys. Acta. 1400:233-255.
48. Travis, L.B. 2002. Therapy-associated solid tumors. Acta Oncol. 41:323-333.
49. Untergasser, G., Koch, H.B., Menssen, A., and Hermeking, H. 2002. Characterization of epithelial senescence by serial analysis of gene expression: Identification of genes potentially involved in prostate cancer. Cancer Res. 62:6255-6262.